These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3017981)

  • 1. The functional domains of coagulation factor VIII:C.
    Burke RL; Pachl C; Quiroga M; Rosenberg S; Haigwood N; Nordfang O; Ezban M
    J Biol Chem; 1986 Sep; 261(27):12574-8. PubMed ID: 3017981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.
    Eaton DL; Wood WI; Eaton D; Hass PE; Hollingshead P; Wion K; Mather J; Lawn RM; Vehar GA; Gorman C
    Biochemistry; 1986 Dec; 25(26):8343-7. PubMed ID: 3030393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
    Marquette KA; Pittman DD; Kaufman RJ
    J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.
    Toole JJ; Pittman DD; Orr EC; Murtha P; Wasley LC; Kaufman RJ
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5939-42. PubMed ID: 3016730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
    Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
    Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular etiology of factor VIII deficiency in hemophilia A.
    Antonarakis SE; Kazazian HH; Tuddenham EG
    Hum Mutat; 1995; 5(1):1-22. PubMed ID: 7728145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain.
    Schwaab R; Ludwig M; Kochhan L; Oldenburg J; McVey JH; Egli H; Brackmann HH; Olek K
    Thromb Res; 1991 Feb; 61(3):225-34. PubMed ID: 1851341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII: structure and function in blood clotting.
    Chavin SI
    Am J Hematol; 1984 Apr; 16(3):297-306. PubMed ID: 6424437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The factor VIII protein and its function.
    Mazurkiewicz-Pisarek A; Płucienniczak G; Ciach T; Płucienniczak A
    Acta Biochim Pol; 2016; 63(1):11-16. PubMed ID: 26824291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor VIII: An overview.
    Bhopale GM; Nanda RK
    J Biosci; 2003 Dec; 28(6):783-9. PubMed ID: 14660878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical properties of normal and haemophilic factor VIII.
    Vermylen J
    Pathol Biol (Paris); 1975 Dec; 23 suppl():5-10. PubMed ID: 772559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII.
    Gale AJ; Pellequer JL; Getzoff ED; Griffin JH
    Thromb Haemost; 2000 Jan; 83(1):78-85. PubMed ID: 10669159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
    Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
    Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.
    Kane WH; Davie EW
    Blood; 1988 Mar; 71(3):539-55. PubMed ID: 3125864
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.
    Parker ET; Healey JF; Barrow RT; Craddock HN; Lollar P
    Blood; 2004 Aug; 104(3):704-10. PubMed ID: 15073030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetics of hemophilia: blood clotting factors VIII and IX.
    Lawn RM
    Cell; 1985 Sep; 42(2):405-6. PubMed ID: 2992799
    [No Abstract]   [Full Text] [Related]  

  • 18. Catabolism of the coagulation factor VIII: can we prolong lifetime of f VIII in circulation?
    Ananyeva NM; Kouiavskaia DV; Shima M; Saenko EL
    Trends Cardiovasc Med; 2001 Aug; 11(6):251-7. PubMed ID: 11673057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequences.
    Levinson B; Janco R; Phillips J; Gitschier J
    Nucleic Acids Res; 1987 Dec; 15(23):9797-805. PubMed ID: 3122181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and sequence of mutations in the factor VIII gene of haemophiliacs.
    Gitschier J; Wood WI; Tuddenham EG; Shuman MA; Goralka TM; Chen EY; Lawn RM
    Nature; 1985 May 30-Jun 5; 315(6018):427-30. PubMed ID: 2987704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.